These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9462431)

  • 1. Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia.
    Rajyaguru JM; Muszynski MJ
    J Antimicrob Chemother; 1997 Dec; 40(6):803-9. PubMed ID: 9462431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
    Rajyaguru JM; Muszynski MJ
    J Antimicrob Chemother; 1997 Sep; 40(3):345-51. PubMed ID: 9338485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.
    Burns JL; Clark DK
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2280-5. PubMed ID: 1280056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance.
    Burns JL; Wadsworth CD; Barry JJ; Goodall CP
    Antimicrob Agents Chemother; 1996 Feb; 40(2):307-13. PubMed ID: 8834871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
    J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
    Lu DC; Chang SC; Chen YC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance patterns and SDS-PAGE protein profiles of Burkholderia cepacia complex isolates from nosocomial and environmental sources in Venezuela.
    Araque-Calderon Y; Miranda-Contreras L; Rodriguez-Lemoine V; Palacios-Pru EL
    Med Sci Monit; 2008 Feb; 14(2):BR49-55. PubMed ID: 18227759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates.
    Aronoff SC
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1636-9. PubMed ID: 2855296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-resistance patterns of clinical isolates of Pseudomonas aeruginosa in regard to their lipopolysaccharide-chain sizes].
    Hasegawa M; Kobayashi I; Saika T; Nishida M
    Kansenshogaku Zasshi; 1996 Jun; 70(6):605-12. PubMed ID: 8741710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    Manno G; Ugolotti E; Belli ML; Fenu ML; Romano L; Cruciani M
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer membrane vesicles produced by
    Kim SY; Kim MH; Son JH; Kim SI; Yun SH; Kim K; Kim S; Shin M; Lee JC
    Virulence; 2020 Dec; 11(1):995-1005. PubMed ID: 32799627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.
    Bernier SP; Son S; Surette MG
    J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.
    Simpson IN; Finlay J; Winstanley DJ; Dewhurst N; Nelson JW; Butler SL; Govan JR
    J Antimicrob Chemother; 1994 Sep; 34(3):353-61. PubMed ID: 7530242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
    Kumar A; Hay MB; Maier GA; Dyke JW
    J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia.
    Albrecht MT; Wang W; Shamova O; Lehrer RI; Schiller NL
    Respir Res; 2002; 3(1):18. PubMed ID: 11980587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of patients with Burkholderia cepacia bacteremia.
    Huang CH; Jang TN; Liu CY; Fung CP; Yu KW; Wong WW
    J Microbiol Immunol Infect; 2001 Sep; 34(3):215-9. PubMed ID: 11605815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas cepacia: the sensitivity of nosocomial strains to new antibiotics.
    Santos Ferreira MO; Canica MM; Bacelar MJ
    J Int Med Res; 1985; 13(5):270-5. PubMed ID: 3902532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
    Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates.
    Saika T; Kobayashi I; Hasegawa M; Nishida M
    J Infect Chemother; 2002 Dec; 8(4):341-4. PubMed ID: 12525895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams.
    Corkill JE; Deveney J; Pratt J; Shears P; Smyth A; Heaf D; Hart CA
    Pediatr Res; 1994 Mar; 35(3):299-302. PubMed ID: 7514780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.